Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Compass Therapeutics (CMPX) Return on Assets (2023 - 2025)

Compass Therapeutics' Return on Assets history spans 3 years, with the latest figure at 0.32% for Q4 2025.

  • For Q4 2025, Return on Assets rose 5.0% year-over-year to 0.32%; the TTM value through Dec 2025 reached 0.32%, up 5.0%, while the annual FY2025 figure was 0.4%, 2.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.32% at Compass Therapeutics, up from 0.4% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.26% in Q4 2023 and bottomed at 0.54% in Q2 2025.
  • The 3-year median for Return on Assets is 0.32% (2024), against an average of 0.36%.
  • The largest YoY upside for Return on Assets was 5bps in 2025 against a maximum downside of -24bps in 2025.
  • A 3-year view of Return on Assets shows it stood at 0.26% in 2023, then tumbled by -40bps to 0.36% in 2024, then rose by 13bps to 0.32% in 2025.
  • Per Business Quant, the three most recent readings for CMPX's Return on Assets are 0.32% (Q4 2025), 0.4% (Q3 2025), and 0.54% (Q2 2025).